CLN5 and neoplasm: ACVR1 inhibitors may hold therapeutic potential as treatment agents targeting the tumor stroma in colorectal cancer; however, BMPs regulate tissue homeostasis by acting on Lgr5+ stem cells in the intestinal epithelium.